Nanobiotix Takes A Big Step, VRTX Broadens Pipeline, PFE Aims High With Javelin
Nanobiotix Takes A Big Step, VRTX Broadens Pipeline, PFE Aims High With Javelin
View ArticleSeattle Genetics Q2 16 Earnings Conference Call At 4:30 PM ET
Seattle Genetics Q2 16 Earnings Conference Call At 4:30 PM ET
View ArticleDVAX To Face FDA Panel, BMY's Opdivo Disappoints, MRK Scores Big With FDA Nod
DVAX To Face FDA Panel, BMY's Opdivo Disappoints, MRK Scores Big With FDA Nod
View ArticleSeattle Genetics To Participate In Morgan Stanley Global Conference At 9:10 AM
Seattle Genetics To Participate In Morgan Stanley Global Conference At 9:10 AM
View ArticleMajor Averages Close Mixed Following Recent Volatility - U.S. Commentary
Major Averages Close Mixed Following Recent Volatility - U.S. Commentary
View ArticleMajor Averages Close Mixed Following Recent Volatility - U.S. Commentary
Major Averages Close Mixed Following Recent Volatility - U.S. Commentary
View ArticleJohnson & Johnson To Present At Credit Suisse Conference; Webcast At 12:00 PM ET
Johnson & Johnson To Present At Credit Suisse Conference; Webcast At 12:00 PM ET
View ArticleSeattle Genetics To Present At Credit Suisse Conference; Webcast At 12:00 PM ET
Seattle Genetics To Present At Credit Suisse Conference; Webcast At 12:00 PM ET
View ArticleSeattle Genetics Announces Clinical Hold On Vadastuximab Talirine Trials
Seattle Genetics Announces Clinical Hold On Vadastuximab Talirine Trials
View ArticleSeattle Genetics Inc. (SGEN) Is Sinking On News Of FDA Clinical Holds
Seattle Genetics Inc. (SGEN) Is Sinking On News Of FDA Clinical Holds
View ArticleANTH Plunges On Failed SOLUTION, All Eyes On CEMP, FDA Says No To AMPH Again
ANTH Plunges On Failed SOLUTION, All Eyes On CEMP, FDA Says No To AMPH Again
View ArticleSeattle Genetics To Present At J.P. Morgan Conference; Webcast At 5:30 PM ET
Seattle Genetics To Present At J.P. Morgan Conference; Webcast At 5:30 PM ET
View ArticleSeattle Genetics Q4 16 Earnings Conference Call At 4:30 PM ET
Seattle Genetics Q4 16 Earnings Conference Call At 4:30 PM ET
View ArticleSeattle Genetics Issues 2017 Revenue Guidance - Quick Facts
Seattle Genetics Issues 2017 Revenue Guidance - Quick Facts
View ArticleImmunomedics Reaches Deal With Seattle Genetics For Sacituzumab Govitecan
Immunomedics Reaches Deal With Seattle Genetics For Sacituzumab Govitecan
View ArticleICPT Catches Investors'' Eyes, TCON Abuzz, IMMU Inks $2Bln Deal With SGEN
ICPT Catches Investors'' Eyes, TCON Abuzz, IMMU Inks $2Bln Deal With SGEN
View ArticleSeattle Genetics Says FDA Lifts Clinical Hold On Vadastuximab Talirine
Seattle Genetics Says FDA Lifts Clinical Hold On Vadastuximab Talirine
View ArticleGainers & Losers Of Mar.9: CBAY, IMMU, TGTX, NSPR, TNDM...
Gainers & Losers Of Mar.9: CBAY, IMMU, TGTX, NSPR, TNDM...
View ArticleSeattle Genetics To Participate In Barclays Healthcare Conference At 10:45 AM ET
Seattle Genetics To Participate In Barclays Healthcare Conference At 10:45 AM ET
View ArticleSeattle Genetics Terminates License Deal With Immunomedics For IMMU-132
Seattle Genetics Terminates License Deal With Immunomedics For IMMU-132
View Article